Skip to main content
Midas Edge

SCIENTIFIC INDUSTRIES INC

For the period ended Sep 30, 2025. Filed Nov 19, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 19, 2025

SCNDStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Changes in Shareholders’ Equity

Additional · AccumulatedOther
Common Stock · Paid-in · Comprehensive · Accumulated · Treasury Stock
Shares · Amount · Capital · Income (Loss) · Deficit · Shares · Amount · Total
Balance December 31, 202410,503,599$525,200$42,637,800$(113,100)$(33,930,500)-$-$9,119,400
Net loss----(1,778,500)--(1,778,500)
Foreign currency translation adjustment---124,400---124,400
Stock-based compensation--302,600----302,600
Balance March 31, 202510,503,599$525,200$42,940,400$11,300$(35,709,000)--$7,767,900
Net loss----(1,523,700)--(1,523,700)
Issuance of Common Stock and Warrants, net of issuance costs (Note 7)1,050,00052,5001,399,700----1,452,200
Foreign currency translation adjustment---155,200---155,200
Stock-based compensation--72,600----72,600
Balance June 30, 202511,553,599$577,700$44,412,700$166,500$(37,232,700)--$7,924,200
Net income----3,994,400--3,994,400
Issuance of Common Stock and Warrants, net of issuance costs (Note 7)375,00018,700481,300----500,000
Foreign currency translation adjustment---(29,800)---(29,800)
Stock-based compensation--72,900----72,900
Balance September 30, 202511,928,599$596,400$44,966,900$136,700$(33,238,300)--$12,461,700
Common Stock · AdditionalPaid-in · AccumulatedOtherComprehensive · Accumulated · Treasury Stock
Shares · Amount · Capital · Income (Loss) · Deficit · Shares · Amount · Total
Balance December 31, 202310,145,211$507,300$40,844,600$18,600$(27,485,100)-$-$13,885,400
Net loss----(2,051,600)--(2,051,600)
Issuance of Common Stock and Warrants, net of issuance costs (Note 7)358,38817,900204,000---221,900
Fair value modification of warrants recorded as stock issuance costs--423,800---423,800
Foreign currency translation adjustment---(60,300)---(60,300)
Stock-based compensation--199,900----199,900
Balance March 31, 202410,503,599$525,200$41,672,300$(41,700)$(29,536,700)--$12,619,100
Net loss----(1,283,600)--(1,283,600)
Issuance of Common Stock and Warrants, net of issuance costs (Note 7)-------
Fair value modification of warrants recorded as stock issuance costs-------
Foreign currency translation adjustment---15,800---15,800
Stock-based compensation--330,300----330,300
Balance June 30, 202410,503,599$525,200$42,002,600$(25,900)$(30,820,300)--$11,681,600
Net loss----(1,180,100)--(1,180,100)
Issuance of Common Stock and Warrants, net of issuance costs (Note 7)-------
Fair value modification of warrants recorded as stock issuance costs-------
Foreign currency translation adjustment---113,600---113,600
Stock-based compensation--319,500----319,500
Balance September 30, 202410,503,599$525,200$42,322,100$87,700$(32,000,400)--$10,934,600

See notes to unaudited condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.